|
Nexalin Technology Inc (NASDAQ: NXL) |
|
Nexalin Technology Inc
NXL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Nexalin Technology Inc 's sales fell
by -47.87 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 2343
Medical Equipment & Supplies industry recorded
deterioration of revenues by -3.26 %
Nexalin Technology Inc faced net loss in contrast to the net income a year ago in first quarter of 2025
• More on NXL's Growth
|
|
Nexalin Technology Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 201.96 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 116.76.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
• More on NXL's Valuation
|
|
|
|
|
Nexalin Technology Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 201.96 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 116.76.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
Nexalin Technology Inc Price to Book Ratio is at 6.58 higher than Industry Avg. of -500.61, and higher than S&P 500 Avg. of 0.01
• More on NXL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com